Market Cap 595.16M
Revenue (ttm) 296.15M
Net Income (ttm) 24.02M
EPS (ttm) N/A
PE Ratio 5.95
Forward PE 3.49
Profit Margin 8.11%
Debt to Equity Ratio -2.69
Volume 1,868,600
Avg Vol 2,184,232
Day's Range N/A - N/A
Shares Out 163.06M
Stochastic %K 80%
Beta 0.25
Analysts Sell
Price Target $6.10

Company Profile

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA name...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 617 621 7722
Fax: 617 494 0480
Address:
100 Summer Street, Suite 2300, Boston, United States
joemist1
joemist1 Jun. 15 at 4:42 PM
$IRWD Bloody swines, move.
0 · Reply
joemist1
joemist1 Jun. 15 at 1:02 PM
$IRWD Come on Epstein class bstrds, let’s go up.
0 · Reply
King_Chase
King_Chase Jun. 15 at 11:42 AM
$5 by this time next week for $IRWD
0 · Reply
Solaf
Solaf Jun. 15 at 5:46 AM
$IRWD Let's see how many days it will will take them to announce that they have paid their debt in full
0 · Reply
Young_Antarian
Young_Antarian Jun. 12 at 6:23 PM
$IRWD shorts burn next week
0 · Reply
joemist1
joemist1 Jun. 12 at 1:43 PM
$IRWD Good morning Epstein class swines, let’s go up.
0 · Reply
wtzou
wtzou Jun. 12 at 11:29 AM
$IRWD Ironwood Pharmaceuticals, Inc. (IRWD), Momentum: A+, Valuation: A. Source: https://seekingalpha.com/news/4602889-these-healthcare-stocks-are-combining-strong-gains-with-reasonable-prices?share_source=shared_news
1 · Reply
ASKING7
ASKING7 Jun. 11 at 6:00 PM
$IRWD @lucullus1 hey Mike, I know you are out of this stock already. I am just curious which platform you use right now to monitor the options activities right now.
1 · Reply
revuelto
revuelto Jun. 11 at 5:39 PM
$IRWD maybe the ironwood gods are against us setting price targets… let’s stop putting numbers on it and see if that finally lets it run😀
1 · Reply
AeroSmith
AeroSmith Jun. 11 at 5:28 PM
$IRWD PE under 6. FPE under 3. Price to cash under 3. Awfully cheap stock.
1 · Reply
Latest News on IRWD
Ironwood Pharmaceuticals Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 5 weeks ago

Ironwood Pharmaceuticals Earnings Call Transcript: Q1 2026


Ironwood Pharmaceuticals Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 5 weeks ago

Ironwood Pharmaceuticals Earnings release: Q1 2026


Ironwood Pharmaceuticals Slides: Q1 2026

May 7, 2026, 8:30 AM EDT - 5 weeks ago

Ironwood Pharmaceuticals Slides: Q1 2026


Ironwood Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 8:30 AM EDT - 5 weeks ago

Ironwood Pharmaceuticals Quarterly report: Q1 2026


Ironwood Pharmaceuticals Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 6 weeks ago

Ironwood Pharmaceuticals Proxy statement: Proxy filing


Ironwood Pharmaceuticals Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 6 weeks ago

Ironwood Pharmaceuticals Proxy statement: Proxy filing


Ironwood to present data from Landmark survey on SBS

2026-04-23T11:25:41.000Z - 7 weeks ago

Ironwood to present data from Landmark survey on SBS


Ironwood price target raised to $10 from $8 at Citizens

2026-02-26T11:08:56.000Z - 3 months ago

Ironwood price target raised to $10 from $8 at Citizens


Ironwood Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 25, 2026, 8:30 AM EST - 3 months ago

Ironwood Pharmaceuticals Earnings Call Transcript: Q4 2025


Ironwood Pharmaceuticals Annual report: Q4 2025

Feb 25, 2026, 8:30 AM EST - 3 months ago

Ironwood Pharmaceuticals Annual report: Q4 2025


Ironwood Pharmaceuticals Earnings release: Q4 2025

Feb 25, 2026, 8:30 AM EST - 3 months ago

Ironwood Pharmaceuticals Earnings release: Q4 2025


Ironwood Pharmaceuticals Slides: Q4 2025

Feb 25, 2026, 8:30 AM EST - 3 months ago

Ironwood Pharmaceuticals Slides: Q4 2025


Craig-Hallum upgrades Ironwood to Buy following 2026 guidance

2026-01-05T12:37:19.000Z - 5 months ago

Craig-Hallum upgrades Ironwood to Buy following 2026 guidance


Ironwood upgraded to Buy from Hold at Craig-Hallum

2026-01-05T12:20:08.000Z - 5 months ago

Ironwood upgraded to Buy from Hold at Craig-Hallum


Ironwood upgraded to Outperform from Market Perform at Citizens

2026-01-05T10:15:33.000Z - 5 months ago

Ironwood upgraded to Outperform from Market Perform at Citizens


Ironwood price target raised to $5 from $3 at Wells Fargo

2026-01-04T23:25:05.000Z - 5 months ago

Ironwood price target raised to $5 from $3 at Wells Fargo


Why Did Ironwood Pharma Stock (IRWD) Jump 30% Today?

2026-01-02T17:29:08.000Z - 5 months ago

Why Did Ironwood Pharma Stock (IRWD) Jump 30% Today?

PFE


Ironwood Pharmaceuticals Earnings release: Q3 2025

Nov 10, 2025, 7:00 AM EST - 7 months ago

Ironwood Pharmaceuticals Earnings release: Q3 2025


Ironwood Pharmaceuticals Quarterly report: Q3 2025

Nov 10, 2025, 7:00 AM EST - 7 months ago

Ironwood Pharmaceuticals Quarterly report: Q3 2025


Ironwood Pharmaceuticals Slides: Q3 2025

Nov 10, 2025, 7:00 AM EST - 7 months ago

Ironwood Pharmaceuticals Slides: Q3 2025


Ironwood Pharmaceuticals Quarterly report: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 11 months ago

Ironwood Pharmaceuticals Quarterly report: Q2 2025


Ironwood Pharmaceuticals Earnings release: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 11 months ago

Ironwood Pharmaceuticals Earnings release: Q2 2025


Ironwood Pharmaceuticals Reports First Quarter 2025 Results

May 7, 2025, 7:05 AM EDT - 1 year ago

Ironwood Pharmaceuticals Reports First Quarter 2025 Results


Ironwood Pharmaceuticals Quarterly report: Q1 2025

May 7, 2025, 7:00 AM EDT - 1 year ago

Ironwood Pharmaceuticals Quarterly report: Q1 2025


Ironwood Pharmaceuticals Earnings release: Q1 2025

May 7, 2025, 7:00 AM EDT - 1 year ago

Ironwood Pharmaceuticals Earnings release: Q1 2025


Ironwood Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Ironwood Pharmaceuticals Proxy statement: Proxy Filing


Ironwood Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Ironwood Pharmaceuticals Proxy statement: Proxy Filing


Ironwood Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Ironwood Pharmaceuticals Earnings Call Transcript: Q4 2024


Ironwood Pharmaceuticals Annual report: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Ironwood Pharmaceuticals Annual report: Q4 2024


Ironwood Pharmaceuticals Earnings release: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

Ironwood Pharmaceuticals Earnings release: Q4 2024


Ironwood Pharmaceuticals Transcript: Status Update

Jan 29, 2025, 4:30 PM EST - 1 year ago

Ironwood Pharmaceuticals Transcript: Status Update


Ironwood Pharmaceuticals Press release: Status Update

Jan 29, 2025, 4:30 PM EST - 1 year ago

Ironwood Pharmaceuticals Press release: Status Update


Ironwood Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Ironwood Pharmaceuticals Earnings Call Transcript: Q3 2024


Ironwood Pharmaceuticals Quarterly report: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Ironwood Pharmaceuticals Quarterly report: Q3 2024


Ironwood Pharmaceuticals Earnings release: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Ironwood Pharmaceuticals Earnings release: Q3 2024


Ironwood Pharmaceuticals Slides: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

Ironwood Pharmaceuticals Slides: Q3 2024


Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Nov 7, 2024, 7:00 AM EST - 1 year ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results


Ironwood Pharmaceuticals Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Ironwood Pharmaceuticals Earnings Call Transcript: Q2 2024


Ironwood Pharmaceuticals Quarterly report: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Ironwood Pharmaceuticals Quarterly report: Q2 2024


Ironwood Pharmaceuticals Earnings release: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Ironwood Pharmaceuticals Earnings release: Q2 2024


Ironwood Pharmaceuticals Slides: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Ironwood Pharmaceuticals Slides: Q2 2024


Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Aug 8, 2024, 7:00 AM EDT - 2 years ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results


joemist1
joemist1 Jun. 15 at 4:42 PM
$IRWD Bloody swines, move.
0 · Reply
joemist1
joemist1 Jun. 15 at 1:02 PM
$IRWD Come on Epstein class bstrds, let’s go up.
0 · Reply
King_Chase
King_Chase Jun. 15 at 11:42 AM
$5 by this time next week for $IRWD
0 · Reply
Solaf
Solaf Jun. 15 at 5:46 AM
$IRWD Let's see how many days it will will take them to announce that they have paid their debt in full
0 · Reply
Young_Antarian
Young_Antarian Jun. 12 at 6:23 PM
$IRWD shorts burn next week
0 · Reply
joemist1
joemist1 Jun. 12 at 1:43 PM
$IRWD Good morning Epstein class swines, let’s go up.
0 · Reply
wtzou
wtzou Jun. 12 at 11:29 AM
$IRWD Ironwood Pharmaceuticals, Inc. (IRWD), Momentum: A+, Valuation: A. Source: https://seekingalpha.com/news/4602889-these-healthcare-stocks-are-combining-strong-gains-with-reasonable-prices?share_source=shared_news
1 · Reply
ASKING7
ASKING7 Jun. 11 at 6:00 PM
$IRWD @lucullus1 hey Mike, I know you are out of this stock already. I am just curious which platform you use right now to monitor the options activities right now.
1 · Reply
revuelto
revuelto Jun. 11 at 5:39 PM
$IRWD maybe the ironwood gods are against us setting price targets… let’s stop putting numbers on it and see if that finally lets it run😀
1 · Reply
AeroSmith
AeroSmith Jun. 11 at 5:28 PM
$IRWD PE under 6. FPE under 3. Price to cash under 3. Awfully cheap stock.
1 · Reply
StockTwitsGhost
StockTwitsGhost Jun. 11 at 5:01 PM
$IRWD Reposting from yesterday. The last two trading sessions can be characterized by notably light volume and highly orderly short covering. The price action suggests that institutional investors are increasingly aware that the debt overhang has been addressed, removing the last key source of uncertainty from the investment thesis. The activity in the options market, suggests hedging flows. Taken together, the underlying equity and derivatives point to rerating accordingly.
1 · Reply
raylin
raylin Jun. 11 at 4:32 PM
$IRWD Tommy, Alex, who the F ever, pump this to fair value!!
0 · Reply
noturfinancrbro
noturfinancrbro Jun. 11 at 4:29 PM
$IRWD why up?
1 · Reply
dartgator
dartgator Jun. 11 at 4:20 PM
$IRWD should be $5+!
0 · Reply
joemist1
joemist1 Jun. 11 at 3:43 PM
$IRWD Yeah Baby Yeah! Make me rich please.
0 · Reply
Young_Antarian
Young_Antarian Jun. 11 at 12:58 PM
$IRWD buyout sometime between June 15 and July 1 seems about right
1 · Reply
StockTwitsGhost
StockTwitsGhost Jun. 10 at 6:42 PM
$IRWD Needed to update my prior statement as it was incorrect. Since 2022 every Ironwood director stands for election annually and can be removed with or without cause, the staggered board was removed. This posture structurally is acquirer friendly governance that often goes unnoticed. There is no poison pill on file that I can find. No rights plan in the Delaware record. There are 75 million authorized preferred shares that exist that are a typical mechanism for a pill but again none have been designated for the purpose of a pill. The board has made itself easier to replace. The charter has made the company easier to acquire.
0 · Reply
StockTwitsGhost
StockTwitsGhost Jun. 10 at 5:58 PM
$IRWD “IRWD 1.50% Convertible Senior Notes due June 15, 2026 (CUSIP 46333XAH1, $200M aggregate principal) are in active maturity settlement. Ironwood has coordinated with the indenture trustee and DTC for full cash retirement at par on June 15 with no revolver utilization. Final semi-annual interest accrual will be distributed concurrent with principal. Holders should expect clean par cash settlement through their custodians on or about June 15.” The conversion feature is meaningless as this is a pure cash maturity event. Post-retirement, Ironwood’s balance sheet transitions to under 1x 2026 adjusted EBITDA leverage, stripping away the last credible financial overhang at precisely the moment STARS-2 confirmatory enrollment has commenced and strategic inbound interest on Apraglutide. $3.38 is absurd.
3 · Reply
raylin
raylin Jun. 10 at 4:23 PM
$IRWD Bring us a hostile takeover bid!!
1 · Reply
Solaf
Solaf Jun. 10 at 4:02 PM
$IRWD can keep gains up as long as a whiskey d1ck
0 · Reply
revuelto
revuelto Jun. 10 at 3:58 PM
$IRWD I am this close to closing my position here…hopefully that means a real re-rating event is just around the corner 🎉😀
0 · Reply
joemist1
joemist1 Jun. 10 at 1:40 PM
$IRWD Good morning mtha fckers, have a nice day.
0 · Reply